194853795	194853795	CD	B-NP	O
|	|	NN	I-NP	O
NVH	NVH	NN	I-NP	O
|	|	NN	I-NP	O
64414838	64414838	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9967499	9967499	CD	B-NP	O
|	|	CC	I-NP	O
1/20/2006	1/20/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Atypical	Atypical	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/1/2006	7/1/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/17/2006	4/17/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
ARBUTHNOT	ARBUTHNOT	NN	B-NP	O
,	,	,	O	O
TERENCE	TERENCE	NN	B-NP	O
919-80-22-6	919-80-22-6	CD	I-NP	O
Ver	Ver	NNP	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/1/06	7/1/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MORVILLO	MORVILLO	NN	B-NP	O
,	,	,	O	O
KRISTOFER	KRISTOFER	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
834134077	834134077	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
IBUPROFEN	IBUPROFEN	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
KETOROLAC	KETOROLAC	NN	B-NP	O
TROMETHAMINE	TROMETHAMINE	NN	I-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
Rash	Rash	NNP	B-NP	O
,	,	,	O	O
GI	GI	NNP	B-NP	O
upset	upset	VBD	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
GI	GI	NNP	B-NP	O
upset	upset	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
home	home	NN	B-NP	O
asa	asa	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
XANAX	XANAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ALPRAZOLAM	ALPRAZOLAM	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Anxiety	Anxiety	NN	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
ALICER	ALICER	NNP	B-NP	O
,	,	,	O	O
CONNIE	CONNIE	NNP	B-NP	O
ELI	ELI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
COLACE	COLACE	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
WHITIKER	WHITIKER	NNP	B-NP	O
,	,	,	O	O
KEVEN	KEVEN	NNP	B-NP	O
KIP	KIP	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
781291307	781291307	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
DYAZIDE	DYAZIDE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/7	9/7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
ZOBELL	ZOBELL	NNP	B-NP	O
,	,	,	O	O
WELDON	WELDON	NNP	B-NP	O
CHAD	CHAD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
673130590	673130590	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
HANTULA	HANTULA	NNP	B-NP	O
,	,	,	O	O
RONNIE	RONNIE	NNP	B-NP	O
CRUZ	CRUZ	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
486197335	486197335	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
MS	MS	NN	I-NP	O
CONTIN	CONTIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MORPHINE	MORPHINE	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
SENNA	SENNA	NNP	I-NP	O
TABLETS	TABLETS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SENNOSIDES	SENNOSIDES	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
ZOCOR	ZOCOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Partial	Partial	JJ	B-NP	O
weight-bearing	weight-bearing	NN	I-NP	O
:	:	:	O	O
Uses	Use	NNS	B-NP	O
cane	cane	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Ken	Ken	NNP	I-NP	O
Igneri	Igneri	NNP	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
for	for	IN	B-PP	O
appt	appt	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
DYAZIDE	DYAZIDE	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
NSAIDs	NSAIDs	NNP	B-NP	O
,	,	,	O	O
Erythromycins	Erythromycins	NNP	B-NP	O
,	,	,	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
,	,	,	O	O
Tape	Tape	NNP	B-NP	O
,	,	,	O	O
IBUPROFEN	IBUPROFEN	NNP	B-NP	O
,	,	,	O	O
KETOROLAC	KETOROLAC	NNP	B-NP	O
TROMETHAMINE	TROMETHAMINE	NNP	I-NP	O
,	,	,	O	O
BUPROPION	BUPROPION	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
GABAPENTIN	GABAPENTIN	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Atypical	Atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Atypical	Atypical	NNP	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
fibromyalgia	fibromyalgia	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
fibromyalgia	fibromyalgia	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
spinal	spinal	JJ	I-NP	B-protein
stenosi	stenosi	NNS	I-NP	I-protein
-LRB-	-LRB-	TO	B-PP	I-protein
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stent	stent	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stent	stent	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TAH	TAH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ccy	ccy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
y/o	y/o	NN	I-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
MI	MI	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
LAD	LAD	NN	B-NP	O
stent	stent	NN	I-NP	O
2004	2004	CD	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperlipdemia	hyperlipdemia	NN	B-NP	O
,	,	,	O	O
complex	complex	JJ	B-NP	O
PMHX	PMHX	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
h/o	h/o	NN	I-NP	O
SSCP	SSCP	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
and	and	CC	O	O
ED	ED	VBN	B-NP	O
visits	visit	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
approx	approx	NN	I-NP	O
>	>	SYM	I-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
since	since	IN	B-PP	O
April	April	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
work-up	work-up	NN	I-NP	O
includes	include	VBZ	B-VP	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/5/06	11/5/06	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
small	small	JJ	I-NP	O
fixed	fixed	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
inferior-basal	inferior-basal	JJ	B-NP	B-protein
region	region	NN	I-NP	I-protein
-	-	HYPH	B-VP	O
likely	likely	RB	I-VP	O
representing	represent	VBG	I-VP	O
soft	soft	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
attenuation	attenuation	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
CTA	CTA	NN	I-NP	B-protein
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
dissection	dissection	NN	I-NP	O
in	in	IN	B-PP	O
6/26/06	6/26/06	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
occ	occ	NN	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
5PM	5PM	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
lightheadedness	lightheadedness	NN	B-NP	O
and	and	CC	I-NP	O
ringing	ringing	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
ears	ear	NNS	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-NP	O
developed	develop	VBN	I-NP	O
SSCP	SSCP	NN	I-NP	O
radiation	radiation	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
back	back	JJ	I-NP	O
and	and	CC	I-NP	O
bilateral	bilateral	JJ	I-NP	O
shoulders	shoulder	NNS	I-NP	O
and	and	CC	O	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
intensity	intensity	NN	I-NP	O
10/10	10/10	CD	I-NP	O
and	and	CC	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
pain	pain	NN	B-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
MI	MI	NN	I-NP	O
and	and	CC	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-VP	O
mult	mult	VB	I-VP	O
prior	prior	JJ	B-NP	O
visits	visit	NNS	I-NP	O
.	.	.	O	O

EMS	EMS	NNS	B-NP	O
called	call	VBN	B-VP	O
and	and	CC	O	O
pt	pt	JJ	B-NP	O
given	give	VBN	I-NP	O
SL	SL	NN	I-NP	B-protein
NTG	NTG	NN	I-NP	I-protein
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
lasted	last	VBD	B-VP	O
approc	approc	NN	B-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
relived	relive	VBN	I-VP	O
with	with	IN	B-PP	O
morphine	morphine	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
report	report	VBP	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
ext	ext	JJ	I-NP	O
cellulites	cellulite	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
7days	7day	NNS	B-NP	O
of	of	IN	B-PP	O
levo	levo	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
warmth	warmth	NN	I-NP	O
and	and	CC	I-NP	O
erythema	erythema	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
ext.	ext.	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
admit	admit	NN	I-NP	O
here	here	RB	B-ADVP	O
6/10	6/10	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
EGD	EGD	NN	I-NP	B-protein
confirming	confirm	VBG	B-VP	O
gastro-jejunal	gastro-jejunal	JJ	B-NP	O
anastamotic	anastamotic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
-	-	HYPH	B-VP	O
told	tell	VBN	I-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
ASA	ASA	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
morphine	morphine	NN	B-NP	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ativan	ativan	NN	B-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
GMS	GMS	NNP	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
ROS	ROS	NN	I-NP	O
:	:	:	O	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
assoc	assoc	NN	I-NP	O
with	with	IN	B-PP	O
old	old	JJ	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
.	.	.	O	O

2wks	2wk	NNS	B-NP	O
smelly	smelly	RB	B-ADVP	O
,	,	,	O	O
dark	dark	JJ	B-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	B-protein
PMH	PMH	NN	I-NP	I-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

CAD	CAD	NN	B-NP	O
a.	a.	RB	I-NP	O
S/P	S/P	NN	I-NP	O
acute	acute	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
MI	MI	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
4/20	4/20	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
b.	b.	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
1/28/04	1/28/04	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
LAD	LAD	NN	B-NP	B-protein
stent	stent	JJ	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
3.5	3.5	CD	B-NP	I-protein
x	x	CC	I-NP	I-protein
23	23	CD	I-NP	I-protein
Cypher	Cypher	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
.	.	.	O	O

LAD	LAD	NN	B-NP	O
had	have	VBD	B-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	I-NP	O
RCA	RCA	NN	I-NP	B-protein
and	and	CC	I-NP	O
LCX	LCX	NN	I-NP	B-protein
were	be	VBD	B-VP	O
patent	patent	JJ	B-NP	O
c.	c.	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
cath	cath	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
5/25	5/25	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
stenoses	stenosis	NNS	I-NP	O
d.	d.	VBP	B-VP	O
Echo	Echo	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/30/2005	4/30/2005	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
EF	EF	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
dilated	dilate	VBN	B-VP	O
LA	LA	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

e.	e.	LS	B-NP	O
S/P	S/P	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
on	on	IN	B-PP	O
9/15/05	9/15/05	CD	B-NP	O
for	for	IN	B-PP	O
hypotensive	hypotensive	JJ	B-NP	O
episode	episode	NN	I-NP	O
and	and	CC	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
requiring	require	VBG	B-VP	O
ICU	ICU	NN	B-NP	O
stay	stay	NN	I-NP	O
at	at	IN	B-PP	O
FH	FH	NNP	B-NP	O
f.	f.	NNP	I-NP	O
Adenosine	Adenosine	NNP	I-NP	O
MIBI	MIBI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/3	8/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
LVEF	LVEF	NN	B-NP	B-protein
:	:	:	O	O
63	63	CD	B-NP	O
%	%	NN	I-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

Stated	State	VBN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-VP	O
no	no	DT	B-NP	O
documentation	documentation	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

UGI	UGI	NNP	B-NP	O
Bleed	Bleed	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/1/06	4/1/06	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
-	-	HYPH	B-NP	O
EGD	EGD	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
friable	friable	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
anastomosis	anastomosis	NN	I-NP	O
site	site	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

Transfused	Transfuse	VBN	B-NP	O
2UPRBCs	2UPRBC	NNS	I-NP	O
4	4	CD	B-NP	O
.	.	.	O	O

Stated	State	VBN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

``	``	``	O	O
Adrenal	Adrenal	JJ	B-NP	O
tumor	tumor	NN	I-NP	O
''	''	''	O	O
8	8	CD	B-NP	O
.	.	.	O	O

H/O	H/O	NN	B-NP	O
DVT	DVT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
1990	1990	CD	I-NP	O
-RRB-	-RRB-	IN	B-PP	O
9	9	CD	B-NP	O
.	.	.	O	O

H/O	H/O	NN	B-NP	B-protein
PE	PE	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
.	.	.	O	O

Fibromyalgia	Fibromyalgia	NNP	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Anxiety	Anxiety	NN	B-NP	O
disorder	disorder	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Anemia	Anemia	NN	B-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

DM2	DM2	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
diet	diet	NN	I-NP	O
controlled	control	VBN	B-VP	O
since	since	IN	B-PP	O
bariatric	bariatric	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NNP	B-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	O
Gastric	Gastric	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
-LRB-	-LRB-	NN	B-NP	O
4/9	4/9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	O
Hysterectomy	Hysterectomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
1990	1990	CD	I-NP	O
-RRB-	-RRB-	IN	B-PP	O
17	17	CD	B-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	O
C-section	C-section	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	O
CCY	CCY	NN	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	O
multiple	multiple	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repairs	repair	VBZ	B-VP	O
20	20	CD	B-NP	O
.	.	.	O	O

H/O	H/O	NN	B-NP	B-protein
UTIs	UTI	NNS	I-NP	I-protein
21	21	CD	B-NP	I-protein
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
22	22	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

Herniated	Herniate	VBN	B-VP	O
Disk	Disk	NNP	B-NP	O
24	24	CD	I-NP	O
.	.	.	O	O

Osteoporosis	Osteoporosis	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
.	.	.	O	O

Carpal	Carpal	JJ	B-NP	O
tunnel	tunnel	NN	I-NP	O
syndromes	syndrome	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
hands	hand	NNS	I-NP	B-protein
26	26	CD	B-NP	I-protein
.	.	.	O	O

Cervical	Cervical	JJ	B-NP	O
spondylosis	spondylosis	NN	I-NP	O
****	****	SYM	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Isosorbide	Isosorbide	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
Levothyroxine	Levothyroxine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
MS	MS	NN	I-NP	O
contin	contin	NN	I-NP	O
30	30	CD	I-NP	O
QID	QID	NNP	I-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
,	,	,	O	O
Dig	Dig	NNP	B-NP	O
0.125	0.125	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
1mg	1mg	NN	I-NP	O
five	five	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NN	B-NP	O
2	2	CD	I-NP	O
q	q	NN	I-NP	O
4h	4h	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
****	****	NNP	I-NP	O
ALL	ALL	NNP	I-NP	O
:	:	:	O	O
PCN	PCN	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
anaphylactic	anaphylactic	JJ	I-NP	O
shock	shock	NN	I-NP	O
,	,	,	O	O
Paxil-feels	Paxil-feels	NNP	B-NP	O
underwater	underwater	NN	I-NP	O
,	,	,	O	O
Toradol-vomiting	Toradol-vomiting	NN	B-NP	O
,	,	,	O	O
Motrin	Motrin	NN	B-NP	O
-	-	HYPH	O	O
bleeding	bleed	VBG	B-VP	O
,	,	,	O	O
Wellbutrin-rash	Wellbutrin-rash	NNP	B-NP	O
,	,	,	O	O
Macrolides-rash	Macrolides-rash	NNP	B-NP	O
,	,	,	O	O
Dyazide-dyspnea	Dyazide-dyspnea	NNP	B-NP	O
,	,	,	O	O
Gabapentin-alopecia	Gabapentin-alopecia	NNP	B-NP	O
,	,	,	O	O
NSAIDS	NSAIDS	NNP	B-NP	O
-	-	HYPH	I-NP	O
GI	GI	NN	I-NP	O
upset	upset	JJ	I-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
h/o	h/o	NN	I-NP	O
tobacco	tobacco	NN	I-NP	O
.	.	.	O	O

Quit	Quit	NN	B-NP	O
approx	approx	NN	I-NP	O
9	9	CD	B-NP	O
mos	mo	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
.	.	.	O	O

Lives	Life	NNS	B-NP	O
with	with	IN	B-PP	O
daughter	daughter	NN	B-NP	O
.	.	.	O	O

Family	Family	RB	B-NP	O
History	History	NN	I-NP	O
:	:	:	O	O
Mother	Mother	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
GIB	GIB	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
pt	pt	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
details	detail	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Sister	Sister	NN	B-NP	O
and	and	CC	I-NP	O
brother	brother	NN	I-NP	O
with	with	IN	B-PP	O
UC	UC	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
sisters	sister	NNS	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
first	first	RB	B-ADVP	O
at	at	IN	B-PP	O
47	47	CD	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
Well	Well	NNP	B-NP	O
appearing	appear	VBG	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
distress	distress	NN	I-NP	B-protein
98	98	CD	I-NP	I-protein
77160/80	77160/80	CD	I-NP	I-protein
16	16	CD	I-NP	I-protein
98	98	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
RA	RA	NN	I-NP	I-protein
,	,	,	O	O
HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

COR	COR	NN	B-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
,	,	,	O	O
S2	S2	NN	B-NP	O
nl	nl	NN	I-NP	O
.	.	.	O	O

1/6	1/6	CD	B-NP	O
SM	SM	NNP	I-NP	O
@	@	NNP	I-NP	O
LUSB	LUSB	NNP	I-NP	O
RESP	RESP	NNP	I-NP	O
:	:	:	O	O
Coarse	Coarse	NNP	B-NP	O
BS	BS	NNP	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
rhonchi	rhonchi	NN	B-NP	O
.	.	.	O	O

ABD	ABD	NN	B-NP	O
:	:	:	O	O
Obese	Obese	NNP	B-NP	O
,	,	,	O	O
BS	BS	NNP	B-NP	O
present	present	NNP	I-NP	O
,	,	,	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
guaiac	guaiac	JJ	I-NP	O
neg	neg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
midline	midline	NN	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
mobile	mobile	JJ	I-NP	O
,	,	,	I-NP	O
slightly	slightly	RB	I-NP	O
tender	tender	NN	I-NP	O
,	,	,	O	O
EXT	EXT	NN	B-NP	O
:	:	:	O	O
WWP	WWP	NN	B-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
+	+	SYM	I-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
LLE	LLE	NN	I-NP	O
>	>	SYM	B-NP	O
RLE	RLE	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
Erythema	Erythema	NN	I-NP	O
,	,	,	O	O
warmth	warmth	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
LLE	LLE	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	B-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
neg	neg	NN	B-NP	O
enzymes	enzyme	NNS	I-NP	O
x2	x2	CD	B-NP	O
,	,	,	O	O
UA	UA	NNP	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	O
29.3	29.3	CD	I-NP	O
with	with	IN	B-PP	O
MCV	MCV	NN	B-NP	B-protein
87.4	87.4	CD	I-NP	I-protein
,	,	,	O	O
dig	dig	NN	B-NP	O
0.6	0.6	CD	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
****	****	SYM	I-NP	O
A	A	NN	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
with	with	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
non-ischemic	non-ischemic	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Doubt	Doubt	NNP	B-NP	O
dissection	dissection	NN	I-NP	O
,	,	,	O	O
doubt	doubt	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	O	O
doubt	doubt	NN	B-NP	O
active	active	JJ	I-NP	O
LE	LE	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
I	I	PRP	B-NP	O
:	:	:	O	O
complete	complete	JJ	B-NP	O
r/o	r/o	NN	I-NP	O
with	with	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
stress	stress	NN	I-NP	O
eval	eval	NN	I-NP	O
req	req	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
,	,	,	O	O
bb	bb	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HEME/ID	HEME/ID	NN	B-NP	O
:	:	:	O	O
doubt	doubt	NN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
or	or	CC	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-NP	O
c/w	c/w	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
2/2	2/2	CD	B-NP	O
chronic	chronic	JJ	I-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
hct	hct	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
w/in	w/in	NN	B-NP	O
baseline	baseline	NN	I-NP	O
,	,	,	O	O
guaiac	guaiac	JJ	B-NP	O
neg	neg	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
known	know	VBN	B-NP	O
gastro-jejunal	gastro-jejunal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
on	on	IN	B-PP	O
EGD	EGD	NN	B-NP	B-DNA
6/10	6/10	CD	I-NP	I-DNA
,	,	,	O	O
guaiac	guaiac	JJ	B-NP	O
neg	neg	NN	I-NP	O
now	now	RB	B-ADVP	O
but	but	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
intermittently	intermittently	RB	I-VP	O
bleeding	bleed	VBG	I-VP	O
given	give	VBN	B-NP	O
h/o	h/o	NN	I-NP	O
dark	dark	JJ	I-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

May	May	MD	O	O
benefit	benefit	NN	B-NP	O
from	from	IN	B-PP	O
repeat	repeat	NN	B-NP	O
EGD	EGD	NN	I-NP	O
.	.	.	O	O

Continuing	Continuing	NNP	B-NP	O
Plavix	Plavix	NNP	I-NP	O
and	and	CC	O	O
ASA	ASA	NNP	B-NP	O
given	give	VBN	B-PP	O
CVA	CVA	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PSYCH	PSYCH	NN	B-NP	B-protein
:	:	:	O	O
cont	cont	VB	B-VP	O
MS	MS	NN	B-NP	B-protein
contin	contin	NN	I-NP	I-protein
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
and	and	CC	I-NP	O
psych	psych	NN	I-NP	O
meds	med	NNS	I-NP	O
-	-	:	O	O
may	may	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
Psych	Psych	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
cardiac	cardiac	JJ	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
lyte	lyte	NN	B-NP	B-protein
scales	scale	NNS	I-NP	I-protein
5	5	CD	B-NP	I-protein
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
ppi	ppi	NN	B-NP	O
,	,	,	O	O
lovenox	lovenox	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Keep	Keep	NNP	B-NP	O
legs	leg	NNS	I-NP	O
elevated	elevate	VBD	B-VP	O
whenever	whenever	WRB	B-ADVP	O
possible	possible	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

GI	GI	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
to	to	TO	B-VP	O
consider	consider	VB	I-VP	O
repeat	repeat	NN	B-NP	O
EGD	EGD	NN	I-NP	O
to	to	TO	B-PP	O
evaluation	evaluation	NN	B-NP	O
Ulcer	Ulcer	NN	I-NP	O
.	.	.	O	O

Holding	Holding	NNP	B-NP	O
Plavix	Plavix	NNP	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Surgery	Surgery	NNP	B-NP	O
follow-up	follow-up	NN	I-NP	O
to	to	TO	B-VP	O
consider	consider	VB	I-VP	O
surgical	surgical	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ALIREZ	ALIREZ	NN	B-NP	B-protein
,	,	,	O	O
MOISES	MOISES	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TC64	TC64	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
7/1/06	7/1/06	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
07	07	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

